Portfolio Company and First Hemp Lifestyle Network Comes to New York to Discuss Opportunities to Become Involved in Booming CBD Industry
SAN DIEGO, April 27, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary, Kannaway®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding its first-ever East Coast Red Carpet Event in Melville, New York on Saturday, April 29. The Red Carpet event provides a unique opportunity to network with top Kannaway® leaders, the company’s executive team, and fellow Kannaway® business owners.
Attendees will hear from several executive team members, including Kannaway® CEO Blake Schroeder and President Brad Tayles, who will outline the Company’s recent successes, discuss new developments, and share the tools needed for brand ambassadors to quickly advance their Kannaway® business.
Also on hand will be CEO of Kannaway® parent company Medical Marijuana, Inc. Dr. Stuart Titus who will share his expertise with CBD, hemp, and the endocannabinoid system to help brand ambassadors understand the myriad of benefits in Kannaway® products. Attendees will also hear from top Kannaway® leaders and earners, including Valerie Aloisio, who will reveal their own personal experiences with Kannaway® to energize other ambassadors’ success.
“We are thrilled to be hosting our first-ever East Coast Red Carpet event in New York,” said Kannaway® CEO Blake Schroeder. “Our Company continues to grow in a CBD market that’s estimated to balloon into a $2.1 billion market within the next three years, so we are excited to get the word out about the Kannaway® system and immense possibilities given by being part of the Kannaway® business to a new audience on the East Coast.”
Advanced tickets to the Kannaway® Red Carpet Event at the Melville Marriot in Melville, NY on April 29 from 1-4 p.m. are available now for just $20 and can be purchased online. Tickets can also be purchased the day of the event for $40 at the door.
Prior to the Red Carpet Event, Kannaway® will host one of our Business Opportunity Meetings from 11:30-12:30 a.m. the day of the event. These meetings, which are free of charge, are a chance for you to invite your potential Kannaway® prospects to learn more about the Kannaway® business. Interested prospects can choose to buy a ticket to the ensuing Red Carpet Event after at the Business Opportunity Meeting.
Please visit here to learn more about Kannaway®’s New York Red Carpet Event and to purchase tickets.
About Kannaway, LLC
Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.